Maike Sander
Overview
Explore the profile of Maike Sander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
6662
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Melton R, Jimenez S, Elison W, Tucciarone L, Howell A, Wang G, et al.
bioRxiv
. 2025 Mar;
PMID: 40027657
Cell type-specific regulatory programs that drive type 1 diabetes (T1D) in the pancreas are poorly understood. Here we performed single nucleus multiomics and spatial transcriptomics in up to 32 non-diabetic...
2.
Waite E, Tigue M, Yu M, Lahori D, Kelly K, May C, et al.
Diabetes
. 2024 Nov;
74(3):332-342.
PMID: 39571094
Article Highlights: Current mouse models for assessing islet function in vivo are limited due to unstable and variable hyperglycemia and/or high morbidity. We derived the IsletTester mouse to address these...
3.
Zhou Z, Gong M, Pande A, Margineanu A, Lisewski U, Purfurst B, et al.
iScience
. 2024 Jul;
27(7):110291.
PMID: 39055936
KCNQ1/Kv7, a low-voltage-gated K channel, regulates cardiac rhythm and glucose homeostasis. While mutations are associated with long-QT syndrome and type2 diabetes, its function in human pancreatic cells remains controversial. We...
4.
Gloyn A, Ibberson M, Marchetti P, Powers A, Rorsman P, Sander M, et al.
Nat Metab
. 2024 Jul;
6(7):1415.
PMID: 38956323
No abstract available.
5.
Superti-Furga G, Agostinho M, Bury J, Cook S, Durinx C, Ender A, et al.
FEBS Lett
. 2024 Mar;
598(7):719-724.
PMID: 38514456
The diverse range of organizations contributing to the global research ecosystem is believed to enhance the overall quality and resilience of its output. Mid-sized autonomous research institutes, distinct from universities,...
6.
Wortham M, Ramms B, Zeng C, Benthuysen J, Sai S, Pollow D, et al.
bioRxiv
. 2024 Mar;
PMID: 38464227
Selective and controlled expansion of endogenous β-cells has been pursued as a potential therapy for diabetes. Ideally, such therapies would preserve feedback control of β-cell proliferation to avoid excessive β-cell...
7.
Bender R, ODonnell B, Shergill B, Pham B, Tahmouresie S, Sanchez C, et al.
Biofabrication
. 2023 Dec;
16(2).
PMID: 38128127
Insulin is an essential regulator of blood glucose homeostasis that is produced exclusively bycells within the pancreatic islets of healthy individuals. In those affected by diabetes, immune inflammation, damage, and...
8.
Urizar A, Prause M, Ingerslev L, Wortham M, Sui Y, Sander M, et al.
Cell Death Dis
. 2023 Jul;
14(7):399.
PMID: 37407581
Insufficient insulin secretion is a hallmark of type 2 diabetes and has been attributed to beta cell identity loss characterized by decreased expression of several key beta cell genes. The...
9.
Wang G, Chiou J, Zeng C, Miller M, Matta I, Han J, et al.
Nat Genet
. 2023 May;
55(6):984-994.
PMID: 37231096
Dysfunctional pancreatic islet beta cells are a hallmark of type 2 diabetes (T2D), but a comprehensive understanding of the underlying mechanisms, including gene dysregulation, is lacking. Here we integrate information...
10.
Mastracci T, Apte M, Amundadottir L, Alvarsson A, Artandi S, Bellin M, et al.
Diabetes
. 2023 Apr;
72(8):1173.
PMID: 37116182
No abstract available.